HASSAN ALI BILA

HASSAN ALI BILA


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2024 in Sciences of Phytochemistry
Verified
Journal Article
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
HBHASSAN ALI BILA
HASSAN ALI BILA
BBBashar Bawa
Bashar Bawa
ASAbdulrazaq Sanusi
Abdulrazaq Sanusi
YSYahaya Mohammed Sani
Yahaya Mohammed Sani
HSHassan Halimatu Sadiya
Hassan Halimatu Sadiya
The development of parasite resistance to first-line antimalarial medicines, especially the Artemisinin-based combination therapies (ACTs), has made the research and development of novel antimalarial medications vital. Globimetula oreophila, a plant used in traditional medicine to treat malaria, is a natural product that may provide new antimalarial drugs with fewer side effects, greater efficacy and lower risk of resistance than synthetic drugs. This study aims to evaluate the antiplasmodial properties of G. oreophila's fractions. The plant leaves were air-dried and reduced in size using a pestle and mortar. The pulverized plant was macerated in 70% ethanol and fractionated with solvent in increasing polarity of n-hexane, chloroform, ethyl acetate, and n-butanol to produce the various fractions. The antiplasmodial activity of the n-hexane, chloroform, ethyl acetate, and n-butanol fractions of G. oreophila leaf extract was assessed using an in vivo method in Plasmodium berghei-infected mice via prophylactic, suppressive, and curative test. The fractions' median lethal dose (LD50) was estimated to be greater than 5000 mg/kg in mice. The median effective dose (ED50) of the fractions at doses of 125, 250, and 500 mg/kg produced a significant (p<0.001) decrease in the level of parasitemia. The ethyl acetate fraction had the best antiplasmodium activity compared to other plant fractions. The fractions of G. oreophila showed significant in vivo antiplasmodial activity, which upholds the earlier in vivo findings for the crude extract and its folkloric use. Further study should be carried out to isolate active secondary metabolites responsible for this observed antimalarial activity in all four investigated fractions.

14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
HBHASSAN ALI BILA
HASSAN ALI BILA
BBBashar Bawa
Bashar Bawa
MAmaryam abdullahi
maryam abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HSHassan Halimatu Sadiya
Hassan Halimatu Sadiya
Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. This study investigates the inhibitory properties of quercetin, quercetrin, dihydrostilbene, 4′-methoxy-isoliquiritigenin, and stigmasterol from Globimetula oreophila on plasmepsins through in silico techniques, including ADME predictions and molecular docking. Results reveal strong interactions of these compounds with active site residues, with quercetrin and stigmasterol displaying notable binding affinities. These findings suggest the potential of G. oreophila metabolites as potent plasmepsin inhibitors, offering prospects for malaria treatment and prevention.

28 May 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
HBHASSAN ALI BILA
HASSAN ALI BILA
BBBashar Bawa
Bashar Bawa
Abdulrazaq SanusiAbdulrazaq Sanusi
Abdulrazaq Sanusi
YSYahaya Mohammed Sani
Yahaya Mohammed Sani
HSHassan Halimatu Sadiya
Hassan Halimatu Sadiya
The development of parasite resistance to first-line antimalarial medicines, especially the ACTs, has made the research and development of novel antimalarial medications vital